Výsledky vyhledávání - "M K, Svensson"

Low-density lipoprotein cholesterol reduction with evolocumab and its use in clinical practice: evidence from Swedish national register data

Autor: M K Svensson, S James, A Ravn-Fischer, E Pantev, G Villa, L Schalin, T Cars, S Gustafsson, E Hagstrom

Publikováno v: European Heart Journal. 43

Background/Introduction Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors reduce low density lipoprotein cholesterol (LDL-C) levels by around 50% to 60%, and the risk of cardiovascular events in patients with atherosclerotic cardiovasc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d78002f65097de877d0bb7ecc76df966
https://doi.org/10.1093/eurheartj/ehac544.2680

Zobrazit plný text záznamu

A real-world analysis of characteristics and lipid-lowering therapy use in patients initiating treatment with evolocumab in Sweden

Autor: M K Svensson, S James, A Ravn-Fischer, E Pantev, F Sorio-Vilela, G Villa, T Cars, S Gustafsson, E Hagstrom

Publikováno v: European Heart Journal. 42

Background/Introduction Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors reduce low-density lipoprotein cholesterol (LDL-C) levels and the risk of cardiovascular events in patients with atherosclerotic cardiovascular disease (ASCVD) i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::52c93267128a4054e1c5d817f54dbf43
https://doi.org/10.1093/eurheartj/ehab724.2590

Zobrazit plný text záznamu

Akademický článek

Dual PPAR α/γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia

Autor: O. Samuelsson, P. O. Attman, I. Gause-Nilsson, M. K. Svensson, P. Alaupovic

Publikováno v: PPAR Research, Vol 2013 (2013)

Chronic kidney disease (CKD) is characterised by specific lipoprotein abnormalities and insulin resistance. Dual activation of the peroxisome proliferators-activated receptors (PPAR) α and γ can significantly improve insulin sensitivity. The aim of

Externí odkaz: https://doaj.org/article/a69b9818bc3740d09555f6982c8c200d

Zobrazit plný text záznamu

The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors

Autor: M K, Svensson, M, Tyrberg, L, Nyström, H J, Arnqvist, J, Bolinder, J, Östman, S, Gudbjörnsdottir, M, Landin-Olsson, J W, Eriksson

Publikováno v: Diabetes/metabolism research and reviews. 31(2)

The main objective of this study was to estimate the occurrence of diabetic nephropathy in a population-based cohort of patients diagnosed with diabetes as young adults (15-34 years).All 794 patients registered 1987-1988 in the Diabetes Incidence Stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::54b55f3717b7136ebcca66c216ee0b37
https://pubmed.ncbi.nlm.nih.gov/25044633

Zobrazit plný text záznamu

Dual PPAR α / γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia

Autor: P. Alaupovic, I. Gause-Nilsson, M. K. Svensson, P.-O. Attman, Ola Samuelsson

Publikováno v: PPAR Research
PPAR Research, Vol 2013 (2013)

Chronic kidney disease (CKD) is characterised by specific lipoprotein abnormalities and insulin resistance. Dual activation of the peroxisome proliferators-activated receptors (PPAR)αandγcan significantly improve insulin sensitivity. The aim of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c25662e2f318ad3e6fcc1280caa336
https://pubmed.ncbi.nlm.nih.gov/23606826

Zobrazit plný text záznamu

Akademický článek

Spatial air temperature variations and urban land use - a statistical approach.

Autor: I Eliasson, M K Svensson

Publikováno v: Meteorological Applications; Jun2003, Vol. 10 Issue 2, p135, 15p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání